Intuitive Surgical (ISRG) has been attracting large attention from investors. Several firms and financial institutions, including Silicon Valley Capital Partners, AQR Capital Management, and United Services Automobile Association, among others have expanded their stakes in ISRG. Meanwhile, the company's stock experienced dips amid tariff worries and general market upticks. The firm has unveiled software upgrades for its leading product, da Vinci 5, providing real-time surgical insights. The roll out of the da Vinci 5 Surgical System by MemorialCare drew attention, offering significant computing power for surgical operations. Notably, ISRG reported installing a total of 395 da Vinci systems in Q2 with a forecast of 17% procedure growth. Despite posting solid quarterly achievements, the firm saw a steep decrease in its shares after insider selling. Nonetheless, forecasts about its valuation remain positive, with Baird raising its price target on ISRG from $590 to $600 and Bank of America maintaining its buy rating with a target price of $650. Wall Street also maintains a bullish stance on the company, backed by robust revenue growth and strategic positioning. The firm's stock appears to have considerable room to grow, hinting at a positive outlook.
Intuitive Surgical ISRG News Analytics from Mon, 09 Jun 2025 07:00:00 GMT to Sat, 13 Sep 2025 13:53:26 GMT -
Rating 5
- Innovation 6
- Information 5
- Rumor 2
